Portola Pharmaceuticals Is A Biopharmaceutical Company Developing Innovative Drugs For The Treatment Of Cardiovascular And Inflammatory Diseases Portola’s Two Most Advanced Programs Are In Phase II Clinical Trials: 1) Betrixaban, An Oral, Once-daily Factor Xa Inhibitor Being Developed For Stroke Prevention In Patients With Atrial Fibrillation (SPAF) And For Prevention Of Venous Thromboembolism (VTE) In Various Patient Populations, And 2) Elinogrel, A Direct-acting, Reversible Oral And I.v. ADP Receptor Antagonist Initially Being Developed For Patients With Acute Coronary Syndrome (ACS).
Portola Packaging, Inc. in Clifton Park is a company that specializes in Plastics Products, Nec. Our records show it was established in New York.
Social Media Networks: The New Advertising MeccaFox Business
Want to Promote Your Business?